IDEXX Labs (IDXX) Tops Q1 EPS by 1c

Go back to IDEXX Labs (IDXX) Tops Q1 EPS by 1c

IDEXX Laboratories Announces First Quarter Results

May 4, 2022 6:30 AM EDT

Achieves first quarter revenue growth of 8% reported and organic, driven by CAG Diagnostics recurring revenue growth of 8% reported and 9% organic, building on high prior year growth Continued strong sector demand supports record first quarter premium instrument placements, driving CAG Diagnostics capital instrument revenue growth of 19% reported and 22% organic Delivers EPS of $2.27, representing 3% decline as reported and 3% growth on a comparable basis, reflecting comparisons to strong prior year results and increases in commercial investments Adjusts 2022 guidance to reflect moderated veterinary clinical visit growth levels impacted by... More